title: Immunotoxicological profile of morphine sulfate in B6C3F1 female mice.
abstract: This study was undertaken to investigate a number of immune parameters which may be compromised with exposure to morphine sulfate. Mice were implanted subcutaneously with 8-, 25-, or 75-mg morphine sulfate pellets. Placebo pellets of identical makeup to the 75-mg morphine pellet (without morphine of course) were used as a control. Twenty-four hours after implantation of a 75-mg morphine pellet, blood levels reached a peak of 1610 ng/ml. Corticosterone increased in parallel with morphine and reached a peak level of 966 ng/ml 24 hr after implantation. The dose response of morphine to increase corticosterone, however, was flat. The weight of the lymphoid organs, spleen and thymus, and the liver were significantly reduced in the morphine-treated groups. Morphine treatment was associated with an increase in serum albumin, SGPT, BUN, and alkaline phosphatase indicative of hepatic damage. In contrast to increased serum proteins, the C3 component of complement was reduced in a dose-dependent manner. Leukocyte number in the peripheral blood was significantly reduced, while erythrocyte number and hematocrit were both increased. The number of B cells and T cells was decreased in morphine-treated animals. However, the percentage of T cells relative to B cells was increased. The primary IgM antibody response to the T-dependent antigen, sheep red blood cells, was decreased. Natural killer cell activity was reduced in response to morphine, as was the phagocytic capacity of Kupffer cells. Host-resistance models of Listeria monocytogenes or Streptococcus pneumoniae showed an increased resistance following administration of morphine. This increased host resistance, however, was not due to an increase in antimicrobial action of sera obtained from mice treated with morphine. The majority of morphine's effects on the immune system exhibited a flat dose response, suggesting that these effects may be mediated secondarily through corticosterone.
authors.affiliation: Department of Pharmacology and Toxicology, School of Dentistry, Medical College of Virginia/Virginia Commonwealth University, Richmond 23298.
authors.forename: D G
authors.initials: DG
authors.lastname: LeVier
authors.forename: J A
authors.initials: JA
authors.lastname: McCay
authors.forename: M L
authors.initials: ML
authors.lastname: Stern
authors.forename: L S
authors.initials: LS
authors.lastname: Harris
authors.forename: D
authors.initials: D
authors.lastname: Page
authors.forename: R D
authors.initials: RD
authors.lastname: Brown
authors.forename: D L
authors.initials: DL
authors.lastname: Musgrove
authors.forename: L F
authors.initials: LF
authors.lastname: Butterworth
authors.forename: K L
authors.initials: KL
authors.lastname: White
authors.forename: A E
authors.initials: AE
authors.lastname: Munson
mesh_terms: D000818:Animals; D000917:Antibody Formation / Q000187:drug effects; D003176:Complement C3 / Q000276:immunology; D003601:Cytotoxicity Tests, Immunologic; D004912:Erythrocytes / Q000276:immunology; D005260:Female; D007109:Immunity / Q000187:drug effects*; D007959:Lymphocyte Culture Test, Mixed; D008214:Lymphocytes / Q000187:drug effects; D051379:Mice; D008811:Mice, Inbred DBA; D008815:Mice, Inbred Strains; D009020:Morphine / Q000008:administration & dosage / Q000633:toxicity*; D012756:Sheep / Q000276:immunology
chemical_list: D003176:Complement C3; D009020:Morphine